A phase 1 trial of a novel cell therapy for lymphoma that is highly resistant to standard treatment (highly refractory lymphoma) has published very positive results in the Nature Medicine journal. The therapy, which uses natural killer (NK) cells derived from cord...
A CAR-T cell therapy for acute lymphoblastic leukaemia[1] has recently been approved by the FDA for use in clinical trials in the United States. The therapy is based on cells derived from allogeneic (donor) umbilical cord blood; it is the very first such treatment to...
After two planned transplants from unrelated donors fell through at the very last minute, Australian three-year-old Tommy Bacon is now in remission from a rare, dangerous form of leukaemia following a transplant of the stem cells from his baby sister’s cord blood.[1]...
Last week it was announced that a new gene editing stem cell therapy for beta thalassemia would start to be made available on the NHS. The therapy, called Casgevy, is developed by Vertex Pharmaceuticals and CRISPR Therapeutics and received approval from the UK...
This year’s World Sickle Cell Day is on the 19th June, a day to recognise and raise awareness of the disease, the millions around the world who suffer from it, and ongoing research into how treatment is advancing. With this year’s theme being ‘we are STRONGER...
Wharton’s Jelly Stem Cells Show Promise for Chronic Spinal Cord Injury in New Study
First Cord Blood Treatment for Cerebral Palsy Performed in Australia
Could Cord Tissue Stem Cells Help Manage Type 2 Diabetes?
Early Insights Into Placenta Stem Cell Therapy for Multiple Sclerosis
